HopeStage
Back to all studies
CompletedNCT01596608

Magnetic Seizure Therapy for Treatment-Resistant Depression and Other Conditions

About this title

Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder

Read the official source — NCT01596608
Device studyAges 18–85Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 85 years.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 2012
Recruitment status
Completed
Enrollment listed in the registry
224
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
Canada
Age range
From 18 Years to 85 Years
Official registry ID
NCT01596608
Official title
Show the full official title

Efficacy and Tolerability of Magnetic Seizure Therapy (MST) as an Alternative to Electroconvulsive Therapy (ECT) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Who was this study for?

Listed age limits: 18 years to 85 years.

Want to explore more studies?

Explore studies